Fingerprint
Dive into the research topics of 'Phase II study of radiopeptide Lu-177-octreotate and capecitabine therapy of progressive disseminated neuroendocrine tumours'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of radiopeptide Lu-177-octreotate and capecitabine therapy of progressive disseminated neuroendocrine tumours
P.G. Claringbold, Paul Brayshaw, R.A. Price, J Turner
Research output: Contribution to journal › Article › peer-review
153
Citations
(Scopus)